NRF2, cancer and calorie restriction

Oncogene

Volumn 30, Issue 5, 2011, Pages 505-520

  Martin Montalvo A ^a   Villalba, J M ^b   Navas, P ^c   De Cabo, R ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIVERSITY OF CÓRDOBA   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

calorie restriction; carcinogenesis; NRF2; phytochemicals

Indexed keywords

ANTINEOPLASTIC AGENT; CONCANAVALIN A; CURCUMIN; ETHOXYQUIN; ISOTHIOCYANIC ACID DERIVATIVE; METFORMIN; OLTIPRAZ; PARACETAMOL; RESVERATROL; SULPHORAPHAN; TRANSCRIPTION FACTOR NRF2; TRITERPENOID; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ASTHMA; BONE DISEASE; BRAIN ATROPHY; BREAST CANCER; CALORIC RESTRICTION; CANCER CHEMOTHERAPY; CANCER PREVENTION; CARCINOGENESIS; CARDIOVASCULAR DISEASE; CELL MEMBRANE; CELL PROLIFERATION; CELL PROTECTION; CHRONIC INFLAMMATION; COLON CANCER; DIABETES MELLITUS; DIET SUPPLEMENTATION; DISEASE COURSE; DRUG EFFECT; DRUG INDUCED CANCER; DRUG MECHANISM; ENZYME REGULATION; GALLBLADDER CANCER; HORMONAL REGULATION; HUMAN; IN VIVO STUDY; INSULIN METABOLISM; INTERVENTION STUDY; KNOCKOUT GENE; LIVER CANCER; LUNG CANCER; MUSCLE ATROPHY; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN FUNCTION; PROTEIN TARGETING; RADIATION INDUCED NEOPLASM; REDOX STRESS; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; SOMATIC CELL; TRANSCRIPTION REGULATION;

ANIMALS; CALORIC RESTRICTION; CELL NUCLEUS; HUMANS; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL; NEOPLASMS; NF-E2-RELATED FACTOR 2;

MUS;

EID: 79551646862     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.492     Document Type: Review

References (263)

1. Alam ZI, Daniel SE, Lees AJ, Marsden DC, Jenner P, Halliwell B. (1997a). A generalised increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease. J Neurochem 69: 1326-1329.
2. Alam ZI, Jenner A, Daniel SE, Lees AJ, Cairns N, Marsden CD et al. (1997b). Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra. J Neurochem 69: 1196-1203.
3. Aleksunes LM, Reisman SA, Yeager RL, Goedken MJ, Klaassen CD. (2010). Nuclear factor erythroid 2-related factor 2 deletion impairs glucose tolerance and exacerbates hyperglycemia in type 1 diabetic mice. J Pharmacol Exp Ther 333: 140-151.
4. Andreou KK, Morgan PR. (1981). Effect of dietary restriction on induced hamster cheek pouch carcinogenesis. Arch Oral Biol 26: 525-531.
5. Ansher SS, Dolan P, Bueding E. (1986). Biochemical effects of dithiolthiones. Food Chem Toxicol 24: 405-415.
6. Aoki Y, Sato H, Nishimura N, Takahashi S, Itoh K, Yamamoto M. (2001). Accelerated DNA adduct formation in the lung of the Nrf2 knockout mouse exposed to diesel exhaust. Toxicol Appl Pharmacol 173: 154-160.
7. Auf dem Keller U, Huber M, Beyer TA, Kumin A, Siemes C, Braun S et al. 2006, Nrf transcription factors in keratinocytes are essential for skin tumor prevention but not for wound healing. Mol Cell Biol. 26, 3773-3784.
8. Bae SY, Choi SK, Kim KR, Park CS, Lee SK, Roh HK et al. (2006). Effects of genetic polymorphisms of MDR1, FMO3 and CYP1A2 on susceptibility to colorectal cancer in Koreans. Cancer Sci 97: 774-779.
9. Baguley BC. (2010). Multiple drug resistance mechanisms in cancer. Mol Biotechnol 46: 308-316.
10. Banning A, Kipp A, Schmitmeier S, Lowinger M, Florian S, Krehl S et al. (2008). Glutathione peroxidase 2 inhibits cyclooxygenase-2-mediated migration and invasion of HT-29 adenocarcinoma cells but supports their growth as tumors in nude mice. Cancer Res 68: 9746-9753.
11. Bartke A, Masternak MM, Al-Regaiey KA, Bonkowski MS. (2007). Effects of dietary restriction on the expression of insulin-signaling-related genes in long-lived mutant mice. Interdiscip Top Gerontol 35: 69-82.
12. Birt DF, Merrill Jr AH, Barnett T, Enkvetchakul B, Pour PM, Liotta DC et al. (1998). Inhibition of skin carcinomas but not papillomas by sphingosine, N-methylsphingosine, and N-acetylsphingosine. Nutr Cancer 31: 119-126.
13. Birt DF, Pelling JC, White LT, Dimitroff K, Barnett T. (1991). Influence of diet and calorie restriction on the initiation and promotion of skin carcinogenesis in the SENCAR mouse model. Cancer Res 51: 1851-1854.
14. Birt DF, Pinch HJ, Barnett T, Phan A, Dimitroff K. (1993). Inhibition of skin tumor promotion by restriction of fat and carbohydrate calories in SENCAR mice. Cancer Res 53: 27-31.
15. Birt DF, Przybyszewski J, Wang W, Stewart J, Liu Y. (2004). Identification of molecular targets for dietary energy restriction prevention of skin carcinogenesis: an idea cultivated by Edward Bresnick. J Cell Biochem 91: 258-264.
16. Birt DF, Yaktine A, Duysen E. (1999). Glucocorticoid mediation of dietary energy restriction inhibition of mouse skin carcinogenesis. J Nutr 129: 571S-574S.
17. Bishop NA, Guarente L. (2007). Two neurons mediate diet-restriction- induced longevity in C. elegans. Nature 447: 545-549.
18. Bloom DA, Jaiswal AK. (2003). Phosphorylation of Nrf2 at Ser40 by protein kinase C in response to antioxidants leads to the release of Nrf2 from INrf2, but is not required for Nrf2 stabilization/ accumulation in the nucleus and transcriptional activation of antioxidant response element-mediated NAD(P)H:quinone oxido-reductase-1 gene expression. J Biol Chem 278: 44675-44682.
19. Boissonneault GA, Elson CE, Pariza MW. (1986). Net energy effects of dietary fat on chemically induced mammary carcinogenesis in F344 rats. J Natl Cancer Inst 76: 335-338.
20. Braun S, Hanselmann C, Gassmann MG, auf dem Keller U, Born-Berclaz C, Chan K et al. (2002). Nrf2 transcription factor, a novel target of keratinocyte growth factor action which regulates gene expression and inflammation in the healing skin wound. Mol Cell Biol 22: 5492-5505.
21. Breese CR, Ingram RL, Sonntag WE. (1991). Influence of age and long-term dietary restriction on plasma insulin-like growth factor-1 (IGF-1), IGF-1 gene expression, and IGF-1 binding proteins. J Gerontol 46: B180-B187.
22. Brigelius-Flohe R, Banning A. (2006). Part of the series: from dietary antioxidants to regulators in cellular signaling and gene regulation. Sulforaphane and selenium, partners in adaptive response and prevention of cancer. Free Radic Res 40: 775-787.
23. Brown-Borg HM, Borg KE, Meliska CJ, Bartke A. (1996). Dwarf mice and the ageing process. Nature 384: 33.
24. Burton NC, Kensler TW, Guilarte TR. (2006). In vivo modulation of the Parkinsonian phenotype by Nrf2. Neurotoxicology 27: 1094-1100.
25. Butt AJ, Fraley KA, Firth SM, Baxter RC. (2002). IGF-binding protein-3-induced growth inhibition and apoptosis do not require cell surface binding and nuclear translocation in human breast cancer cells. Endocrinology 143: 2693-2699.
26. Cabral JR, Neal GE. (1983). The inhibitory effects of ethoxyquin on the carcinogenic action of aflatoxin B1 in rats. Cancer Lett 19: 125-132.
27. Cakatay U, Telci A, Kayali R, Tekeli F, Akcay T, Sivas A. (2001). Relation of oxidative protein damage and nitrotyrosine levels in the aging rat brain. Exp Gerontol 36: 221-229.
28. Calkins MJ, Jakel RJ, Johnson DA, Chan K, Kan YW, Johnson JA. (2005). Protection from mitochondrial complex II inhibition in vitro and in vivo by Nrf2-mediated transcription. Proc Natl Acad Sci USA 102: 244-249.
29. Campbell JK, Canene-Adams K, Lindshield BL, Boileau TW, Clinton SK, Erdman Jr JW. (2004). Tomato phytochemicals and prostate cancer risk. J Nutr 134: 3486S-3492S.
30. Cao J, Schulte J, Knight A, Leslie NR, Zagozdzon A, Bronson R et al. (2009). Prdx1 inhibits tumorigenesis via regulating PTEN/AKT activity. EMBO J 28: 1505-1517.
31. Castello L, Froio T, Maina M, Cavallini G, Biasi F, Leonarduzzi G et al. (2010). Alternate-day fasting protects the rat heart against age-induced inflammation and fibrosis by inhibiting oxidative damage and NF-kB activation. Free Radic Biol Med 48: 47-54.
32. Clinton SK, Emenhiser C, Schwartz SJ, Bostwick DG, Williams AW, Moore BJ et al. (1996). Cis-trans lycopene isomers, carotenoids, and retinol in the human prostate. Cancer Epidemiol Biomarkers Prev 5: 823-833.
33. Cohen ND, Hilf R. (1974). Influence of insulin on growth and metabolism of 7,12-dimethylbenz(alpha)anthracene-induced mammary tumors. Cancer Res 34: 3245-3252.
34. Colman RJ, Anderson RM, Johnson SC, Kastman EK, Kosmatka KJ, Beasley TM et al. (2009). Caloric restriction delays disease onset and mortality in rhesus monkeys. Science 325: 201-204.
35. Collins AR, Lyon CJ, Xia X, Liu JZ, Tangirala RK, Yin F et al. (2009). Age-accelerated atherosclerosis correlates with failure to upregulate antioxidant genes. Circ Res 104: e42-e54.
36. Cullinan SB, Gordan JD, Jin J, Harper JW, Diehl JA. (2004). The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: oxidative stress sensing by a Cul3-Keap1 ligase. Mol Cell Biol 24: 8477-8486.
37. Cullinan SB, Zhang D, Hannink M, Arvisais E, Kaufman RJ, Diehl JA. (2003). Nrf2 is a direct PERK substrate and effector of PERK-dependent cell survival. Mol Cell Biol 23: 7198-7209.
38. Chan JM, Giovannucci EL. (2001). Vegetables, fruits, associated micronutrients, and risk of prostate cancer. Epidemiol Rev 23: 82-86.
39. Chan JY, Han XL, Kan YW. (1993a). Cloning of Nrf1, an NF-E2-related transcription factor, by genetic selection in yeast. Proc Natl Acad Sci USA 90: 11371-11375.
40. Chan JY, Han XL, Kan YW. (1993b). Isolation of cDNA encoding the human NF-E2 protein. Proc Natl Acad Sci USA 90: 11366-11370.
41. Chandrasekar B, McGuff HS, Aufdermorte TB, Troyer DA, Talal N, Fernandes G. (1995). Effects of calorie restriction on transforming growth factor beta 1 and proinflammatory cytokines in murine Sjogren's syndrome. Clin Immunol Immunopathol 76: 291-296.
42. Chang XZ, Li DQ, Hou YF, Wu J, Lu JS, Di GH et al. (2007). Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer. Breast Cancer Res 9: R76.
43. Chartoumpekis D, Ziros PG, Psyrogiannis A, Kyriazopoulou V, Papavassiliou AG, Habeos IG. (2010). Simvastatin lowers reactive oxygen species level by Nrf2 activation via PI3K/Akt pathway. Biochem Biophys Res Commun 396: 463-466.
44. Chen C, Yu R, Owuor ED, Kong AN. (2000). Activation of antioxidant-response element (ARE), mitogen-activated protein kinases (MAPKs) and caspases by major green tea polyphenol components during cell survival and death. Arch Pharm Res 23: 605-612.
45. Chen XL, Varner SE, Rao AS, Grey JY, Thomas S, Cook CK et al. (2003). Laminar flow induction of antioxidant response element-mediated genes in endothelial cells. A novel anti-inflammatory mechanism. J Biol Chem 278: 703-711.
46. Cheney KE, Liu RK, Smith GS, Meredith PJ, Mickey MR, Walford RL. (1983). The effect of dietary restriction of varying duration on survival, tumor patterns, immune function, and body temperature in B10C3F1 female mice. J Gerontol 38: 420-430.
47. Chiao JW, Wu H, Ramaswamy G, Conaway CC, Chung FL, Wang L et al. (2004). Ingestion of an isothiocyanate metabolite from cruciferous vegetables inhibits growth of human prostate cancer cell xenografts by apoptosis and cell cycle arrest. Carcinogenesis 25: 1403-1408.
48. Dai G, Vaughn S, Zhang Y, Wang ET, Garcia-Cardena G, Gimbrone Jr MA. (2007). Biomechanical forces in atherosclerosis-resistant vascular regions regulate endothelial redox balance via phosphoi-nositol 3-kinase/Akt-dependent activation of Nrf2. Circ Res 101: 723-733.
49. Davies KJ. (2001). Degradation of oxidized proteins by the 20S proteasome. Biochimie 83: 301-310.
50. De Cabo R, Cabello R, Rios M, Lopez-Lluch G, Ingram DK, Lane MA et al. (2004). Calorie restriction attenuates age-related alterations in the plasma membrane antioxidant system in rat liver. Exp Gerontol 39: 297-304.
51. Derjuga A, Gourley TS, Holm TM, Heng HH, Shivdasani RA, Ahmed R et al. (2004). Complexity of CNC transcription factors as revealed by gene targeting of the Nrf3 locus. Mol Cell Biol 24: 3286-3294.
52. Devling TW, Lindsay CD, McLellan LI, McMahon M, Hayes JD. (2005). Utility of siRNA against Keap1 as a strategy to stimulate a cancer chemopreventive phenotype. Proc Natl Acad Sci USA 102: 7280-7285A.
53. Dexter DT, Carter CJ, Wells FR, Javoy-Agid F, Agid Y, Lees A et al. (1989). Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J Neurochem 52: 381-389.
54. Ding Y, Choi KJ, Kim JH, Han X, Piao Y, Jeong JH et al. (2008). Endogenous hydrogen peroxide regulates glutathione redox via nuclear factor erythroid 2-related factor 2 downstream of phospha-tidylinositol 3-kinase during muscle differentiation. Am J Pathol 172: 1529-1541.
55. Dinkova-Kostova AT, Fahey JW, Talalay P. (2004). Chemical structures of inducers of nicotinamide quinone oxidoreductase 1 (NQO1). Methods Enzymol 382: 423-448.
56. Dinkova-Kostova AT, Holtzclaw WD, Cole RN, Itoh K, Wakabaya-shi N, Katoh Y et al. (2002). Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc Natl Acad Sci USA 99: 11908-11913.
57. Dinkova-Kostova AT, Massiah MA, Bozak RE, Hicks RJ, Talalay P. (2001). Potency of Michael reaction acceptors as inducers of enzymes that protect against carcinogenesis depends on their reactivity with sulfhydryl groups. Proc Natl Acad Sci USA 98: 3404-3409.
58. Djuric Z, Kritschevsky D. (1993). Modulation of oxidative DNA damage levels by dietary fat and calories. Mutat Res 295: 181-190.
59. Duan W, Zhang R, Guo Y, Jiang Y, Huang Y, Jiang H et al. (2009). Nrf2 activity is lost in the spinal cord and its astrocytes of aged mice. In vitro Cell Dev Biol Anim 45: 388-397.
60. Efferth T, Volm M. (2005). Glutathione-related enzymes contribute to resistance of tumor cells and low toxicity in normal organs to artesunate. In vivo 19: 225-232.
61. Eggler AL, Liu G, Pezzuto JM, van Breemen RB, Mesecar AD. (2005). Modifying specific cysteines of the electrophile-sensing human Keap1 protein is insufficient to disrupt binding to the Nrf2 domain Neh2. Proc Natl Acad Sci USA 102: 10070-10075.
62. Fahey JW, Zhang Y, Talalay P. (1997). Broccoli sprouts: an exceptionally rich source of inducers of enzymes that protect against chemical carcinogens. Proc Natl Acad Sci USA 94: 10367-10372.
63. Favreau LV, Pickett CB. (1991). Transcriptional regulation of the rat NAD(P)H:quinone reductase gene. Identification of regulatory elements controlling basal level expression and inducible expression by planar aromatic compounds and phenolic antiox-idants. J Biol Chem 266: 4556-4561.
64. Fialka F, Gruber RM, Hitt R, Opitz L, Brunner E, Schliephake H et al. (2008). CPA6, FMO2, LGI1, SIAT1 and TNC are differentially expressed in early- and late-stage oral squamous cell carcinoma-a pilot study. Oral Oncol 44: 941-948.
65. Fields WR, Morrow CS, Doehmer J, Townsend AJ. (1999). Expression of stably transfected murine glutathione S-transferase A3-3 protects against nucleic acid alkylation and cytotoxicity by aflatoxin B1 in hamster V79 cells expressing rat cytochrome P450-2B1. Carcinogen-esis 20: 1121-1125.
66. Fitzmaurice PS, Shaw IC, Kleiner HE, Miller RT, Monks TJ, Lau SS et al. (1996). Evidence for DNA damage in amyotrophic lateral sclerosis. Muscle Nerve 19: 797-798.
67. Franke TF. (2008). PI3K/Akt: getting it right matters. Oncogene 27: 6473-6488.
68. Friling RS, Bensimon A, Tichauer Y, Daniel V. (1990). Xenobiotic-inducible expression of murine glutathione S-transferase Ya subunit gene is controlled by an electrophile-responsive element. Proc Natl Acad Sci USA 87: 6258-6262.
69. Furukawa M, Xiong Y. (2005). BTB protein Keap1 targets antioxidant transcription factor Nrf2 for ubiquitination by the Cullin 3-Roc1 ligase. Mol Cell Biol 25: 162-171.
70. Garcea R, Daino L, Frassetto S, Cozzolino P, Ruggiu ME, Vannini MG et al. (1988). Reversal by ribo- and deoxyribonucleosides of dehydroepiandrosterone- induced inhibition of enzyme altered foci in the liver of rats subjected to the initiation-selection process of experimental carcinogenesis. Carcinogenesis 9: 931-938.
71. Gerhauser C, You M, Liu J, Moriarty RM, Hawthorne M, Mehta RG et al. (1997). Cancer chemopreventive potential of sulforamate, a novel analogue of sulforaphane that induces phase 2 drug-metabolizing enzymes. Cancer Res 57: 272-278.
72. Giovannucci E, Ascherio A, Rimm EB, Stampfer MJ, Colditz GA, Willett WC. (1995). Intake of carotenoids and retinol in relation to risk of prostate cancer. J Natl Cancer Inst 87: 1767-1776.
73. Gordon GB, Shantz LM, Talalay P. (1987). Modulation of growth, differentiation and carcinogenesis by dehydroepiandrosterone. Adv Enzyme Regul 26: 355-382.
74. Greer EL, Brunet A. (2005). FOXO transcription factors at the interface between longevity and tumor suppression. Oncogene 24: 7410-7425.
75. Gross L, Dreyfuss Y. (1986). Inhibition of the development of radiation-induced leukemia in mice by reduction of food intake. Proc Natl Acad Sci USA 83: 7928-7931.
76. Guo Z, Mitchell-Raymundo F, Yang H, Ikeno Y, Nelson J, Diaz V et al. (2002). Dietary restriction reduces atherosclerosis and oxidative stress in the aorta of apolipoprotein E-deficient mice. Mech Ageing Dev 123: 1121-1131.
77. Halagappa VK, Guo Z, Pearson M, Matsuoka Y, Cutler RG, Laferla FM et al. (2007). Intermittent fasting and caloric restriction ameliorate age-related behavioral deficits in the triple-transgenic mouse model of Alzheimer's disease. Neurobiol Dis 26: 212-220.
78. Halliwell B. (1992). Reactive oxygen species and the central nervous system. J Neurochem 59: 1609-1623.
79. Halliwell B. (1996a). Free radicals, proteins and DNA: oxidative damage versus redox regulation. Biochem Soc Trans 24: 1023-1027. (Pubitemid 26417963)
80. Halliwell B. (1996b). Oxidative stress, nutrition and health. Experimental strategies for optimization of nutritional antioxidant intake in humans. Free Radic Res 25: 57-74.
81. Halliwell B. (2001). Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging 18: 685-716.
82. Hansen BC, Ortmeyer HK, Bodkin NL. (1995). Prevention of obesity in middle-aged monkeys: food intake during body weight clamp. Obes Res 3(Suppl 2): 199s-204s.
83. Hayes JD, Chanas SA, Henderson CJ, McMahon M, Sun C, Moffat GJ et al. (2000). The Nrf2 transcription factor contributes both to the basal expression of glutathione S-transferases in mouse liver and to their induction by the chemopreventive synthetic antioxidants, butylated hydroxyanisole and ethoxyquin. Biochem Soc Trans 28: 33-41.
84. Hayes JD, McMahon M. (2009). NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer. Trends Biochem Sci 34: 176-188.
85. Hecht SS, Chung FL, Richie Jr JP, Akerkar SA, Borukhova A, Skowronski L et al. (1995). Effects of watercress consumption on metabolism of a tobacco-specific lung carcinogen in smokers. Cancer Epidemiol Biomarkers Prev 4: 877-884.
86. Heiss E, Herhaus C, Klimo K, Bartsch H, Gerhauser C. (2001). Nuclear factor kappa B is a molecular target for sulforaphane-mediated anti-inflammatory mechanisms. J Biol Chem 276: 32008-32015.
87. Henderson CJ, Smith AG, Ure J, Brown K, Bacon EJ, Wolf CR. (1998). Increased skin tumorigenesis in mice lacking pi class glutathione S-transferases. Proc Natl Acad Sci USA 95: 5275-5280.
88. Hennessy BT, Smith DL, Ram PT, Lu Y, Mills GB. (2005). Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat Rev Drug Discov 4: 988-1004.
89. Holloszy JO, Fontana L. (2007). Caloric restriction in humans. Exp Gerontol 42: 709-712.
90. Hong WK, Sporn MB. (1997). Recent advances in chemoprevention of cancer. Science 278: 1073-1077.
91. Howell TH. (1987). The art of living long by Luigi Cornaro. Age Ageing 16: 194-195.
92. Hu R, Xu C, Shen G, Jain MR, Khor TO, Gopalkrishnan A et al. (2006). Gene expression profiles induced by cancer chemopreventive isothiocyanate sulforaphane in the liver of C57BL/6J mice and C57BL/6J/Nrf2 (-/-) mice. Cancer Lett 243: 170-192.
93. Huang HC, Nguyen T, Pickett CB. (2002). Phosphorylation of Nrf2 at Ser-40 by protein kinase C regulates antioxidant response element-mediated transcription. J Biol Chem 277: 42769-42774.
94. Hursting SD, Lavigne JA, Berrigan D, Perkins SN, Barrett JC. (2003). Calorie restriction, aging, and cancer prevention: mechanisms of action and applicability to humans. Annu Rev Med 54: 131-152.
95. Hursting SD, Perkins SN, Phang JM. (1994). Calorie restriction delays spontaneous tumorigenesis in p53-knockout transgenic mice. Proc Natl Acad Sci USA 91: 7036-7040.
96. Hyer ML, Croxton R, Krajewska M, Krajewski S, Kress CL, Lu M et al. (2005). Synthetic triterpenoids cooperate with tumor necrosis factor-related apoptosis-inducing ligand to induce apoptosis of breast cancer cells. Cancer Res 65: 4799-4808.
97. Hyun DH, Emerson SS, Jo DG, Mattson MP, de Cabo R. (2006). Calorie restriction up-regulates the plasma membrane redox system in brain cells and suppresses oxidative stress during aging. Proc Natl Acad Sci USA 103: 19908-19912.
98. Hyun DH, Hunt ND, Emerson SS, Hernandez JO, Mattson MP, de Cabo R. (2007). Up-regulation of plasma membrane-associated redox activities in neuronal cells lacking functional mitochondria. J Neurochem 100: 1364-1374.
99. Iida K, Itoh K, Kumagai Y, Oyasu R, Hattori K, Kawai K et al. (2004). Nrf2 is essential for the chemopreventive efficacy of oltipraz against urinary bladder carcinogenesis. Cancer Res 64: 6424-6431.
100. Ingram DK, Cutler RG, Weindruch R, Renquist DM, Knapka JJ, April M et al. (1990). Dietary restriction and aging: the initiation of a primate study. J Gerontol 45: B148-B163.
101. Itoh K, Chiba T, Takahashi S, Ishii T, Igarashi K, Katoh Y et al. (1997). An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun 236: 313-322.
102. Itoh K, Igarashi K, Hayashi N, Nishizawa M, Yamamoto M. (1995). Cloning and characterization of a novel erythroid cell-derived CNC family transcription factor heterodimerizing with the small Maf family proteins. Mol Cell Biol 15: 4184-4193.
103. Itoh K, Wakabayashi N, Katoh Y, Ishii T, Igarashi K, Engel JD et al. (1999). Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev 13: 76-86.
104. Jakel RJ, Townsend JA, Kraft AD, Johnson JA. (2007). Nrf2-mediated protection against 6-hydroxydopamine. Brain Res 1144: 192-201.
105. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. (2009). Cancer statistics, 2009. CA Cancer J Clin 59: 225-249.
106. Jenner P. (2003). Oxidative stress in Parkinson's disease. Ann Neurol 53(Suppl 3): S26-S36; discussion S36-38.
107. Jiang T, Huang Z, Lin Y, Zhang Z, Fang D, Zhang DD. (2010). The protective role of Nrf2 in streptozotocin-induced diabetic nephro-pathy. Diabetes 59: 850-860.
108. Jimenez-Hidalgo M, Santos-Ocana C, Padilla S, Villalba JM, Lopez-Lluch G, Martin-Montalvo A et al. (2009). NQR1 controls lifespan by regulating the promotion of respiratory metabolism in yeast. Aging Cell 8: 140-151.
109. Johnson JB, Summer W, Cutler RG, Martin B, Hyun DH, Dixit VD et al. (2007). Alternate day calorie restriction improves clinical findings and reduces markers of oxidative stress and inflammation in overweight adults with moderate asthma. Free Radic Biol Med 42: 665-674.
110. Juge N, Mithen RF, Traka M. (2007). Molecular basis for chemoprevention by sulforaphane: a comprehensive review. Cell Mol Life Sci 64: 1105-1127.
111. Jung KJ, Lee EK, Kim JY, Zou Y, Sung B, Heo HS et al. (2009). Effect of short term calorie restriction on pro-inflammatory NF-kB and AP-1 in aged rat kidney. Inflamm Res 58: 143-150.
112. Kalaany NY, Sabatini DM. (2009). Tumours with PI3K activation are resistant to dietary restriction. Nature 458: 725-731.
113. Kang MI, Kobayashi A, Wakabayashi N, Kim SG, Yamamoto M. (2004). Scaffolding of Keap1 to the actin cytoskeleton controls the function of Nrf2 as key regulator of cytoprotective phase 2 genes. Proc Natl Acad Sci USA 101: 2046-2051.
114. Kanninen K, Heikkinen R, Malm T, Rolova T, Kuhmonen S, Leinonen H et al. (2009). Intrahippocampal injection of a lentiviral vector expressing Nrf2 improves spatial learning in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 106: 16505-16510.
115. Kensler TW, Egner PA, Dolan PM, Groopman JD, Roebuck BD. (1987). Mechanism of protection against aflatoxin tumorigenicity in rats fed 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) and related 1,2-dithiol-3-thiones and 1,2-dithiol-3-ones. Cancer Res 47: 4271-4277.
116. Kensler TW, Helzlsouer KJ. (1995). Oltipraz: clinical opportunities for cancer chemoprevention. p. J Cell Biochem Suppl 22: 101-107.
117. Kensler TW, Wakabayashi N, Biswal S. (2007). Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol 47: 89-116.
118. Khor TO, Huang MT, Kwon KH, Chan JY, Reddy BS, Kong AN. (2006). Nrf2-deficient mice have an increased susceptibility to dextran sulfate sodium-induced colitis. Cancer Res 66: 11580-11584.
119. Khor TO, Yu S, Kong AN. (2008). Dietary cancer chemopreventive agents-targeting inflammation and Nrf2 signaling pathway. Planta Med 74: 1540-1547.
120. Kiritoshi S, Nishikawa T, Sonoda K, Kukidome D, Senokuchi T, Matsuo T et al. (2003). Reactive oxygen species from mitochondria induce cyclooxygenase-2 gene expression in human mesangial cells: potential role in diabetic nephropathy. Diabetes 52: 2570-2577.
121. Kitamura Y, Umemura T, Kanki K, Kodama Y, Kitamoto S, Saito K et al. (2007). Increased susceptibility to hepatocarcinogenicity of Nrf2-deficient mice exposed to 2-amino-3-methylimidazo[4,5-f]qui-noline. Cancer Sci 98: 19-24.
122. Klaassen CD, Slitt AL. (2005). Regulation of hepatic transporters by xenobiotic receptors. Curr Drug Metab 6: 309-328.
123. Klurfeld DM, Weber MM, Kritchevsky D. (1987). Inhibition of chemically induced mammary and colon tumor promotion by caloric restriction in rats fed increased dietary fat. Cancer Res 47: 2759-2762.
124. Kobayashi A, Ito E, Toki T, Kogame K, Takahashi S, Igarashi K et al. (1999). Molecular cloning and functional characterization of a new Cap'n' collar family transcription factor Nrf3. J Biol Chem 274: 6443-6452.
125. Kobayashi A, Kang MI, Okawa H, Ohtsuji M, Zenke Y, Chiba T et al. (2004a). Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol Cell Biol 24: 7130-7139.
126. Kobayashi A, Ohta T, Yamamoto M. (2004b). Unique function of the Nrf2-Keap1 pathway in the inducible expression of antioxidant and detoxifying enzymes. Methods Enzymol 378: 273-286.
127. Kobayashi M, Itoh K, Suzuki T, Osanai H, Nishikawa K, Katoh Y et al. (2002). Identification of the interactive interface and phylogenic conservation of the Nrf2-Keap1 system. Genes Cells 7: 807-820.
128. Kraft AD, Johnson DA, Johnson JA. (2004). Nuclear factor E2-related factor 2-dependent antioxidant response element activation by tert-butylhydroquinone and sulforaphane occurring preferentially in astrocytes conditions neurons against oxidative insult. J Neurosci 24: 1101-1112.
129. Kritchevsky D. (2001). Caloric restriction and cancer. J Nutr Sci Vitaminol (Tokyo) 47: 13-19.
130. Kritchevsky D, Weber MM, Klurfeld DM. (1984). Dietary fat versus caloric content in initiation and promotion of 7,12-dimethylben-z(a)anthracene-induced mammary tumorigenesis in rats. Cancer Res 44: 3174-3177.
131. Kwak MK, Itoh K, Yamamoto M, Kensler TW. (2002). Enhanced expression of the transcription factor Nrf2 by cancer chemopreven-tive agents: role of antioxidant response element-like sequences in the nrf2 promoter. Mol Cell Biol 22: 2883-2892.
132. 3H-1, 2-dimethiole-3-thione. Mol Med 7: 135-145.
133. Kwak MK, Wakabayashi N, Greenlaw JL, Yamamoto M, Kensler TW. (2003a). Antioxidants enhance mammalian proteasome expression through the Keap1-Nrf2 signaling pathway. Mol Cell Biol 23: 8786-8794.
134. Kwak MK, Wakabayashi N, Itoh K, Motohashi H, Yamamoto M, Kensler TW. (2003b). Modulation of gene expression by cancer chemopreventive dithiolethiones through the Keap1-Nrf2 pathway. Identification of novel gene clusters for cell survival. J Biol Chem 278: 8135-8145.
135. Lagopoulos L, Stalder R. (1987). The influence of food intake on the development of diethylnitrosamine-induced liver tumours in mice. Carcinogenesis 8: 33-37.
136. Lal S, Sandanaraj E, Wong ZW, Ang PC, Wong NS, Lee EJ et al. (2008). CBR1 and CBR3 pharmacogenetics and their influence on doxorubicin disposition in Asian breast cancer patients. Cancer Sci 99: 2045-2054.
137. Lapillonne H, Konopleva M, Tsao T, Gold D, McQueen T, Sutherland RL et al. (2003). Activation of peroxisome prolifera-tor-activated receptor gamma by a novel synthetic triterpenoid2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces growth arrest and apoptosis in breast cancer cells. Cancer Res 63: 5926-5939.
138. Lee HH, Park SA, Almazari I, Kim EH, Na HK, Surh YJ. (2010a). Piceatannol induces heme oxygenase-1 expression in human mammary epithelial cells through activation of ARE-driven Nrf2 signaling. Arch Biochem Biophys 501: 142-150.
139. Lee JM, Calkins MJ, Chan K, Kan YW, Johnson JA. (2003a). Identification of the NF-E2-related factor-2-dependent genes conferring protection against oxidative stress in primary cortical astrocytes using oligonucleotide microarray analysis. J Biol Chem 278: 12029-12038.
140. Lee JM, Li J, Johnson DA, Stein TD, Kraft AD, Calkins MJ et al. (2005a). Nrf2, a multi-organ protector? FASEB J 19: 1061-1066.
141. Lee JM, Shih AY, Murphy TH, Johnson JA. (2003b). NF-E2-related factor-2 mediates neuroprotection against mitochondrial complex I inhibitors and increased concentrations of intracellular calcium in primary cortical neurons. J Biol Chem 278: 37948-37956.
142. Lee KW, Ma L, Yan X, Liu B, Zhang XK, Cohen P. (2005b). Rapid apoptosis induction by IGFBP-3 involves an insulin-like growth factor-independent nucleomitochondrial translocation of RXRal-pha/Nur77. J Biol Chem 280: 16942-16948.
143. Lee SK, Lee CY, Kook YA, Lee SK, Kim EC. (2010b). Mechanical stress promotes odontoblastic differentiation via the heme oxyge-nase-1 pathway in human dental pulp cell line. Life Sci 86: 107-114.
144. Leifert WR, Abeywardena MY. (2008). Cardioprotective actions of grape polyphenols. Nutr Res 28: 729-737.
145. Leonard MO, Kieran NE, Howell K, Burne MJ, Varadarajan R, Dhakshinamoorthy S et al. (2006). Reoxygenation-specific activation of the antioxidant transcription factor Nrf2 mediates cytopro-tective gene expression in ischemia-reperfusion injury. FASEB J 20: 2624-2626.
146. Li Y, Jaiswal AK. (1992). Regulation of human NAD(P)H:quinone oxidoreductase gene. Role of AP1 binding site contained within human antioxidant response element. J Biol Chem 267: 15097-15104.
147. Lii CK, Liu KL, Cheng YP, Lin AH, Chen HW, Tsai CW. (2010). Sulforaphane and alpha-lipoic acid upregulate the expression of the pi class of glutathione S-transferase through c-jun and Nrf2 activation. J Nutr 140: 885-892.
148. Liu XM, Peyton KJ, Ensenat D, Wang H, Hannink M, Alam J et al. (2007). Nitric oxide stimulates heme oxygenase-1 gene transcription via the Nrf2/ARE complex to promote vascular smooth muscle cell survival. Cardiovasc Res 75: 381-389.
149. Lok E, Nera EA, Iverson F, Scott F, So Y, Clayson DB. (1988). Dietary restriction, cell proliferation and carcinogenesis: a preliminary study. Cancer Lett 38: 249-255.
150. Love R. (2005). Calorie restriction may be neuroprotective in AD and PD. Lancet Neurol 4: 84.
151. Maher J, Yamamoto M. (2010). The rise of antioxidant signaling-the evolution and hormetic actions of Nrf2. Toxicol Appl Pharmacol 244: 4-15.
152. Mandlekar S, Hong JL, Kong AN. (2006). Modulation of metabolic enzymes by dietary phytochemicals: a review of mechanisms underlying beneficial versus unfavorable effects. Curr Drug Metab 7: 661-675.
153. Manjgaladze M, Chen S, Frame LT, Seng JE, Duffy PH, Feuers RJ et al. (1993). Effects of caloric restriction on rodent drug and carcinogen metabolizing enzymes: implications for mutagenesis and cancer. Mutat Res 295: 201-222.
154. Marzetti E, Lees HA, Wohlgemuth SE, Leeuwenburgh C. (2009). Sarcopenia of aging: underlying cellular mechanisms and protection by calorie restriction. Biofactors 35: 28-35.
155. Masoro EJ. (1995). Antiaging action of caloric restriction: endocrine and metabolic aspects. Obes Res 3(Suppl 2): 241s-247s.
156. Mattison JA, Roth GS, Lane MA, Ingram DK. (2007). Dietary restriction in aging nonhuman primates. Interdiscip Top Gerontol 35: 137-158.
157. Mattson MP. (2003). Will caloric restriction and folate protect against AD and PD? Neurology 60: 690-695.
158. Mattson MP, Duan W, Lee J, Guo Z. (2001). Suppression of brain aging and neurodegenerative disorders by dietary restriction and environmental enrichment: molecular mechanisms. Mech Ageing Dev 122: 757-778.
159. McKiernan SH, Bua E, McGorray J, Aiken J. (2004). Early-onset calorie restriction conserves fiber number in aging rat skeletal muscle. FASEB J 18: 580-581.
160. McMahon M, Itoh K, Yamamoto M, Chanas SA, Henderson CJ, McLellan LI et al. (2001). The Cap'n'Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes. Cancer Res 61: 3299-3307.
161. McMahon M, Itoh K, Yamamoto M, Hayes JD. (2003). Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression. J Biol Chem 278: 21592-21600.
162. McMahon M, Thomas N, Itoh K, Yamamoto M, Hayes JD. (2004). Redox-regulated turnover of Nrf2 is determined by at least two separate protein domains, the redox-sensitive Neh2 degron and the redox-insensitive Neh6 degron. J Biol Chem 279: 31556-31567.
163. Miller EC, Giovannucci E, Erdman Jr JW, Bahnson R, Schwartz SJ, Clinton SK. (2002). Tomato products, lycopene, and prostate cancer risk. Urol Clin N Am 29: 83-93. (Pubitemid 34733104)
164. Mitra A, Shevde LA, Samant RS. (2009). Multi-faceted role of HSP40 in cancer. Clin Exp Metastasis 26: 559-567.
165. Miyagi S, Iwama N, Kawabata T, Hasegawa K. (2003). Longevity and diet in Okinawa, Japan: the past, present and future. Asia Pac J Public Health 15(Suppl): S3-S9.
166. Moi P, Chan K, Asunis I, Cao A, Kan YW. (1994). Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region. Proc Natl Acad Sci USA 91: 9926-9930.
167. Moreschi C. (1909). Beziehungen zwischen Ernahrung und Tumor-wachstum. Z fur Immunitatsforsch 2: 661-675.
168. Mostoslavsky R, Chua KF, Lombard DB, Pang WW, Fischer MR, Gellon L et al. (2006). Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell 124: 315-329.
169. Motohashi H, Katsuoka F, Engel JD, Yamamoto M. (2004). Small Maf proteins serve as transcriptional cofactors for keratinocyte differentiation in the Keap1-Nrf2 regulatory pathway. Proc Natl Acad Sci USA 101: 6379-6384.
170. Motohashi H, Yamamoto M. (2004). Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol Med 10: 549-557.
171. Muguruma M, Nishimura J, Jin M, Kashida Y, Moto M, Takahashi M et al. (2006). Molecular pathological analysis for determining the possible mechanism of piperonyl butoxide-induced hepatocarcino-genesis in mice. Toxicology 228: 178-187.
172. 0-flanking region of the human gamma-glutamylcysteine synthetase heavy subunit gene. Biochem Biophys Res Commun 209: 227-233.
173. Murakami S, Johnson TE. (1996). A genetic pathway conferring life extension and resistance to UV stress in Caenorhabditis elegans. Genetics 143: 1207-1218.
174. 0 enhancer. EMBO J 17: 5734-5743.
175. Nagaraj S, Youn JI, Weber H, Iclozan C, Lu L, Cotter MJ et al. (2010). Anti-inflammatory triterpenoid blocks immune suppressive function of MDSCs and improves immune response in cancer. Clin Cancer Res 16: 1812-1823.
176. Nair S, Xu C, Shen G, Hebbar V, Gopalakrishnan A, Hu R et al. (2006). Pharmacogenomics of phenolic antioxidant butylated hydroxyanisole (BHA) in the small intestine and liver of Nrf2 knockout and C57BL/6J mice. Pharm Res 23: 2621-2637.
177. Nguyen T, Sherratt PJ, Huang HC, Yang CS, Pickett CB. (2003). Increased protein stability as a mechanism that enhances Nrf2-mediated transcriptional activation of the antioxidant response element. Degradation of Nrf2 by the 26 S proteasome. J Biol Chem 278: 4536-4541.
178. Nguyen T, Yang CS, Pickett CB. (2004). The pathways and molecular mechanisms regulating Nrf2 activation in response to chemical stress. Free Radic Biol Med 37: 433-441.
179. Nguyen TV, Janssen MJ, van Oijen MG, Bergevoet SM, te Morsche RH, van Asten H et al. (2010). Genetic polymorphisms in GSTA1, GSTP1, GSTT1, and GSTM1 and gastric cancer risk in a Vietnamese population. Oncol Res 18: 349-355.
180. Nioi P, Nguyen T. (2007). A mutation of Keap1 found in breast cancer impairs its ability to repress Nrf2 activity. Biochem Biophys Res Commun 362: 816-821.
181. Nolan KA, Scott KA, Barnes J, Doncaster J, Whitehead RC. (2010). Stratford IJ Pharmacological inhibitors of NAD(P)H quinone oxidoreductase, NQO1: structure/activity relationships and functional activity in tumour cells. Biochem Pharmacol 80: 977-981.
182. Numazawa S, Ishikawa M, Yoshida A, Tanaka S, Yoshida T. (2003). Atypical protein kinase C mediates activation of NF-E2-related factor 2 in response to oxidative stress. Am J Physiol Cell Physiol 285: C334-C342.
183. Okawa H, Motohashi H, Kobayashi A, Aburatani H, Kensler TW, Yamamoto M. (2006). Hepatocyte-specific deletion of the keap1 gene activates Nrf2 and confers potent resistance against acute drug toxicity. Biochem Biophys Res Commun 339: 79-88.
184. Onken B, Driscoll M. (2010). Metformin induces a dietary restrictionlike state and the oxidative stress response to extend C. elegans healthspan via AMPK, LKB1, and SKN-1. PLoS One 5: e8758.
185. Osburn WO, Yates MS, Dolan PD, Chen S, Liby KT, Sporn MB et al. (2008). Genetic or pharmacologic amplification of nrf2 signaling inhibits acute inflammatory liver injury in mice. Toxicol Sci 104: 218-227.
186. Oyake T, Itoh K, Motohashi H, Hayashi N, Hoshino H, Nishizawa M et al. (1996). Bach proteins belong to a novel family of BTB-basic leucine zipper transcription factors that interact with MafK and regulate transcription through the NF-E2 site. Mol Cell Biol 16: 6083-6095.
187. Padmanabhan B, Tong KI, Ohta T, Nakamura Y, Scharlock M, Ohtsuji M et al. (2006). Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer. Mol Cell 21: 689-700.
188. Palli D, Vineis P, Russo A, Berrino F, Krogh V, Masala G et al. (2000). Diet, metabolic polymorphisms and DNA adducts: the EPIC-Italy cross-sectional study. Int J Cancer 87: 444-451. (Pubitemid 30451659)
189. Pashko LL, Lewbart ML, Schwartz AG. (1991). Inhibition of 12-O-tetradecanoylphorbol-13-acetate-promoted skin tumor formation in mice by 16 alpha-fluoro-5-androsten-17-one and its reversal by deoxyribonucleosides. Carcinogenesis 12: 2189-2192.
190. Pashko LL, Schwartz AG. (1992). Reversal of food restriction-induced inhibition of mouse skin tumor promotion by adrenalectomy. Carcinogenesis 13: 1925-1928.
191. Patel M, Lu L, Zander DS, Sreerama L, Coco D, Moreb JS. (2008). ALDH1A1 and ALDH3A1 expression in lung cancers: correlation with histologic type and potential precursors. Lung Cancer 59: 340-349.
192. Pearson KJ, Lewis KN, Price NL, Chang JW, Perez E, Cascajo MV et al. (2008). Nrf2 mediates cancer protection but not prolongevity induced by caloric restriction. Proc Natl Acad Sci USA 105: 2325-2330.
193. Philip M, Rowley DA, Schreiber H. (2004). Inflammation as a tumor promoter in cancer induction. Semin Cancer Biol 14: 433-439.
194. Pietsch EC, Chan JY, Torti FM, Torti SV. (2003). Nrf2 mediates the induction of ferritin H in response to xenobiotics and cancer chemopreventive dithiolethiones. J Biol Chem 278: 2361-2369.
195. Pollak M. (2009). Macronutrient intake and cancer: how does dietary restriction influence tumor growth and why should we care? Cancer Prev Res (Phila Pa) 2: 698-701.
196. Pollard M, Luckert PH, Pan GY. (1984). Inhibition of intestinal tumorigenesis in methylazoxymethanol-treated rats by dietary restriction. Cancer Treat Rep 68: 405-408.
197. Pratico D, Delanty N. (2000). Oxidative injury in diseases of the central nervous system: focus on Alzheimer's disease. Am J Med 109: 577-585.
198. Prestera T, Talalay P, Alam J, Ahn YI, Lee PJ, Choi AM. (1995). Parallel induction of heme oxygenase-1 and chemoprotective phase 2 enzymes by electrophiles and antioxidants: regulation by upstream antioxidant-responsive elements (ARE). Mol Med 1: 827-837.
199. Pugh TD, Oberley TD, Weindruch R. (1999). Dietary intervention at middle age: caloric restriction but not dehydroepiandrosterone sulfate increases lifespan and lifetime cancer incidence in mice. Cancer Res 59: 1642-1648.
200. Qin W, Zhao W, Ho L, Wang J, Walsh K, Gandy S et al. (2008). Regulation of forkhead transcription factor FoxO3a contributes to calorie restriction-induced prevention of Alzheimer's disease-type amyloid neuropathology and spatial memory deterioration. Ann N Y Acad Sci 1147: 335-347.
201. Ramos-Gomez M, Dolan PM, Itoh K, Yamamoto M, Kensler TW. (2003). Interactive effects of nrf2 genotype and oltipraz on benzo[a]pyrene-DNA adducts and tumor yield in mice. Carcinogen-esis 24: 461-467.
202. Ramos-Gomez M, Kwak MK, Dolan PM, Itoh K, Yamamoto M, Talalay P et al. (2001). Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice. Proc Natl Acad Sci USA 98: 3410-3415.
203. Ramsey JJ, Colman RJ, Binkley NC, Christensen JD, Gresl TA, Kemnitz JW et al. (2000). Dietary restriction and aging in rhesus monkeys: the University of Wisconsin study. Exp Gerontol 35: 1131-1149.
204. Rangasamy T, Cho CY, Thimmulappa RK, Zhen L, Srisuma SS, Kensler TW et al. (2004). Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice. J Clin Invest 114: 1248-1259.
205. Rangasamy T, Guo J, Mitzner WA, Roman J, Singh A, Fryer AD et al. (2005). Disruption of Nrf2 enhances susceptibility to severe airway inflammation and asthma in mice. J Exp Med 202: 47-59.
206. Reinhart J, Pearson WR. (1993). The structure of two murine class-mu glutathione transferase genes coordinately induced by butylated hydroxyanisole. Arch Biochem Biophys 303: 383-393.
207. Rous P. (1914). The influence of diet on transplanted and spontaneous tumors. J Exp Med 20: 433-451.
208. Ruggeri BA, Klurfeld DM, Kritchevsky D, Furlanetto RW. (1989). Caloric restriction and 7,12-dimethylbenz(a)anthracene-induced mammary tumor growth in rats: alterations in circulating insulin, insulin-like growth factors I and II, and epidermal growth factor. Cancer Res 49: 4130-4134.
209. Rushmore TH, Pickett CB. (1990). Transcriptional regulation of the rat glutathione S-transferase Ya subunit gene. Characterization of a xenobiotic-responsive element controlling inducible expression by phenolic antioxidants. J Biol Chem 265: 14648-14653.
210. Sell C. (2003). Caloric restriction and insulin-like growth factors in aging and cancer. Horm Metab Res 35: 705-711.
211. Shantz LM, Talalay P, Gordon GB. (1989). Mechanism of inhibition of growth of 3T3-L1 fibroblasts and their differentiation to adipocytes by dehydroepiandrosterone and related steroids: role of glucose-6-phosphate dehydrogenase. Proc Natl Acad Sci USA 86: 3852-3856.
212. Shaw PJ, Ince PG, Falkous G, Mantle D. (1995). Oxidative damage to protein in sporadic motor neuron disease spinal cord. Ann Neurol 38: 691-695.
213. Shen G, Xu C, Hu R, Jain MR, Gopalkrishnan A, Nair S et al. (2006). Modulation of nuclear factor E2-related factor 2-mediated gene expression in mice liver and small intestine by cancer chemopre-ventive agent curcumin. Mol Cancer Ther 5: 39-51.
214. Shibata T, Kokubu A, Gotoh M, Ojima H, Ohta T, Yamamoto M et al. (2008). Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer. Gastroenterology 135: 1358-1368; e1-4.
215. Shih AY, Imbeault S, Barakauskas V, Erb H, Jiang L, Li P et al. (2005). Induction of the Nrf2-driven antioxidant response confers neuroprotection during mitochondrial stress in vivo. J Biol Chem 280: 22925-22936.
216. Shih AY, Johnson DA, Wong G, Kraft AD, Jiang L, Erb H et al. (2003). Coordinate regulation of glutathione biosynthesis and release by Nrf2-expressing glia potently protects neurons from oxidative stress. J Neurosci 23: 3394-3406.
217. Shih PH, Yen GC. (2007). Differential expressions of antioxidant status in aging rats: the role of transcriptional factor Nrf2 and MAPK signaling pathway. Biogerontology 8: 71-80.
218. Shimokawa I, Yu BP, Masoro EJ. (1991). Influence of diet on fatal neoplastic disease in male Fischer 344 rats. J Gerontol 46: B228-B232.
219. Shou M, Dai R, Cui D, Korzekwa KR, Baillie TA, Rushmore TH. (2001). A kinetic model for the metabolic interaction of two substrates at the active site of cytochrome P450 3A4. J Biol Chem 276: 2256-2262.
220. Singh A, Misra V, Thimmulappa RK, Lee H, Ames S, Hoque MO et al. (2006). Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer. PLoS Med 3: e420.
221. 0s disease. Free Radic Biol Med 49: 147-158.
222. Stadtman ER, Berlett BS. (1998). Reactive oxygen-mediated protein oxidation in aging and disease. Drug Metab Rev 30: 225-243.
223. Stewart JW, Koehler K, Jackson W, Hawley J, Wang W, Au A et al. (2005). Prevention of mouse skin tumor promotion by dietary energy restriction requires an intact adrenal gland and glucocorticoid supplementation restores inhibition. Carcinogenesis 26: 1077-1084.
224. Suh JH, Shenvi SV, Dixon BM, Liu H, Jaiswal AK, Liu RM et al. (2004). Decline in transcriptional activity of Nrf2 causes age-related loss of glutathione synthesis, which is reversible with lipoic acid. Proc Natl Acad Sci USA 101: 3381-3386.
225. Suzuki M. (2001). Cultural climate and social custom for longevity region, Okinawa]. Nippon Ronen Igakkai Zasshi 38: 163-165.
226. Suzuki T, Takagi Y, Osanai H, Li L, Takeuchi M, Katoh Y et al. (2005). Pi class glutathione S-transferase genes are regulated by Nrf 2 through an evolutionarily conserved regulatory element in zebrafish. Biochem J 388: 65-73.
227. Sykiotis GP, Bohmann D. (2008). Keap1/Nrf2 signaling regulates oxidative stress tolerance and lifespan in Drosophila. Dev Cell 14: 76-85.
228. Tannenbaum A, Silverstone H. (1949). The genesis and growth of tumors; effects of varying the proportion of protein (casein) in the diet. Cancer Res 9: 162-173.
229. Tannenbaum A, Silverstone H. (1953). Nutrition in relation to cancer. Adv Cancer Res 1: 451-501.
230. Taub R, Roy A, Dieter R, Koontz J. (1987). Insulin as a growth factor in rat hepatoma cells. Stimulation of proto-oncogene expression. J Biol Chem 262: 10893-10897.
231. Thatcher GR, Bennett BM, Reynolds JN. (2005). Nitric oxide mimetic molecules as therapeutic agents in Alzheimer's disease. Curr Alzheimer Res 2: 171-182.
232. Thimmulappa RK, Mai KH, Srisuma S, Kensler TW, Yamamoto M, Biswal S. (2002). Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. Cancer Res 62: 5196-5203.
233. Thompson HJ, Zhu Z, Jiang W. (2003). Dietary energy restriction in breast cancer prevention. J Mammary Gland Biol Neoplasia 8: 133-142.
234. Toki T, Itoh J, Kitazawa J, Arai K, Hatakeyama K, Akasaka J et al. (1997). Human small Maf proteins form heterodimers with CNC family transcription factors and recognize the NF-E2 motif. Oncogene 14: 1901-1910.
235. Tong KI, Katoh Y, Kusunoki H, Itoh K, Tanaka T, Yamamoto M. (2006a). Keap1 recruits Neh2 through binding to ETGE and DLG motifs: characterization of the two-site molecular recognition model. Mol Cell Biol 26: 2887-2900.
236. Tong KI, Kobayashi A, Katsuoka F, Yamamoto M. (2006b). Two-site substrate recognition model for the Keap1-Nrf2 system: a hinge and latch mechanism. Biol Chem 387: 1311-1320.
237. Tullet JM, Hertweck M, An JH, Baker J, Hwang JY, Liu S et al. (2008). Direct inhibition of the longevity-promoting factor SKN-1 by insulin-like signaling in C. elegans. Cell 132: 1025-1038.
238. Udenigwe CC, Ramprasath VR, Aluko RE, Jones PJ. (2008). Potential of resveratrol in anticancer and anti-inflammatory therapy. Nutr Rev 66: 445-454.
239. Ungvari Z, Parrado-Fernandez C, Csiszar A, de Cabo R. (2008). Mechanisms underlying caloric restriction and lifespan regulation: implications for vascular aging. Circ Res 102: 519-528.
240. Volchegorskii IA, Shemyakov SE, Turygin VV, Malinovskaya NV. (2004). The age dynamics of monoamine oxidase activity and levels of lipid peroxidation products in the human brain. Neurosci Behav Physiol 34: 303-305.
241. Wakabayashi N, Dinkova-Kostova AT, Holtzclaw WD, Kang MI, Kobayashi A, Yamamoto M et al (2004). Protection against electrophile and oxidant stress by induction of the phase 2 response: fate of cysteines of the Keap1 sensor modified by inducers. Proc Natl Acad Sci USA 101: 2040-2045.
242. Wakabayashi N, Itoh K, Wakabayashi J, Motohashi H, Noda S, Takahashi S et al. (2003). Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation. Nat Genet 35: 238-245.
243. Wang H, Xing J, Wang F, Han W, Ren H, Wu T et al. (2010). Expression of Hsp27 and Hsp70 in lymphocytes and plasma in healthy workers and coal miners with lung cancer. J Huazhong Univ Sci Technol Med Sci 30: 415-420.
244. Warabi E, Takabe W, Minami T, Inoue K, Itoh K, Yamamoto M et al. (2007). Shear stress stabilizes NF-E2-related factor 2 and induces antioxidant genes in endothelial cells: role of reactive oxygen/nitrogen species. Free Radic Biol Med 42: 260-269.
245. Warita H, Hayashi T, Murakami T, Manabe Y, Abe K. (2001). Oxidative damage to mitochondrial DNA in spinal motoneurons of transgenic ALS mice. Brain Res Mol Brain Res 89: 147-152.
246. Wasserman WW, Fahl WE. (1997). Functional antioxidant responsive elements. Proc Natl Acad Sci USA 94: 5361-5366.
247. Wattenberg LW. (1972). Inhibition of carcinogenic and toxic effects of polycyclic hydrocarbons by phenolic antioxidants and ethoxyquin. J Natl Cancer Inst 48: 1425-1430.
248. Weed JL, Lane MA, Roth GS, Speer DL, Ingram DK. (1997). Activity measures in rhesus monkeys on long-term calorie restriction. Physiol Behav 62: 97-103.
249. Weindruch R, Walford RL. (1982). Dietary restriction in mice beginning at 1 year of age: effect on life-span and spontaneous cancer incidence. Science 215: 1415-1418. (Pubitemid 12129729)
250. Westerbeek ZW, Hepple RT, Zernicke RF. (2008). Effects of aging and caloric restriction on bone structure and mechanical properties. J Gerontol A 63: 1131-1136.
251. 2 via an antioxidant response element. FASEB J 19: 2085-2087.
252. Willcox BJ, Willcox DC, Todoriki H, Fujiyoshi A, Yano K, He Q et al. (2007). Caloric restriction, the traditional Okinawan diet, and healthy aging: the diet of the world's longest-lived people and its potential impact on morbidity and life span. Ann N Y Acad Sci 1114: 434-455.
253. Williams KV, Mullen ML, Kelley DE, Wing RR. (1998). The effect of short periods of caloric restriction on weight loss and glycemic control in type 2 diabetes. Diabetes Care 21: 2-8.
254. Xu C, Huang MT, Shen G, Yuan X, Lin W, Khor TO et al. (2006). Inhibition of 7,12-dimethylbenz(a)anthracene-induced skin tumor-igenesis in C57BL/6 mice by sulforaphane is mediated by nuclear factor E2-related factor 2. Cancer Res 66: 8293-8296.
255. Xue M, Qian Q, Adaikalakoteswari A, Rabbani N, Babaei-Jadidi R, Thornalley PJ. (2008). Activation of NF-E2-related factor-2 reverses biochemical dysfunction of endothelial cells induced by hypergly-cemia linked to vascular disease. Diabetes 57: 2809-2817.
256. Yamamoto T, Kyo M, Kamiya T, Tanaka T, Engel JD, Motohashi H et al. (2006). Predictive base substitution rules that determine the binding and transcriptional specificity of Maf recognition elements. Genes Cells 11: 575-591.
257. Yang H, Shi M, Story J, Richardson A, Guo Z. (2004). Food restriction attenuates age-related increase in the sensitivity of endothelial cells to oxidized lipids. J Gerontol A 59: 316-323.
258. Yates MS, Tauchi M, Katsuoka F, Flanders KC, Liby KT, Honda T et al. (2007). Pharmacodynamic characterization of chemopreven-tive triterpenoids as exceptionally potent inducers of Nrf2-regulated genes. Mol Cancer Ther 6: 154-162.
259. Ye G, Metreveli NS, Donthi RV, Xia S, Xu M, Carlson EC et al. (2004). Catalase protects cardiomyocyte function in models of type 1 and type 2 diabetes. Diabetes 53: 1336-1343.
260. Yu X, Kensler T. (2005). Nrf2 as a target for cancer chemoprevention. Mutat Res 591: 93-102.
261. Zakkar M, Van der Heiden K, Luong le A, Chaudhury H, Cuhlmann S, Hamdulay SS et al. (2009). Activation of Nrf2 in endothelial cells protects arteries from exhibiting a proinflammatory state. Arterioscler Thromb Vasc Biol 29: 1851-1857.
262. Zhang DD, Hannink M. (2003). Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. Mol Cell Biol 23: 8137-8151.
263. Zhang Y, Kensler TW, Cho CG, Posner GH, Talalay P. (1994). Anticarcinogenic activities of sulforaphane and structurally related synthetic norbornyl isothiocyanates. Proc Natl Acad Sci USA 91: 3147-3150.